(Total Views: 771)
Posted On: 06/08/2025 5:54:13 PM
Post# of 154603
The global chemotherapy market was valued at USD 9.55 billion in 2024 and is projected to reach USD 19.87 billion by 2034, according to Statifacts.
The global radiation oncology market size was exhibited at USD 9.75 billion in 2023 and is projected to hit around USD 31.66 billion by 2033
The global PARP Inhibitors Market was valued at approximately USD 7.9 billion in 2023 and is projected to reach USD 8.4 billion in 2024. By 2033, the market is expected to reach about USD 23.5 billion
The CAR T-Cell therapy market size is calculated at $8.46 bn in 2025 is to hit $88.51 bn by 2034.
The global immune checkpoint inhibitor market is projected to reach $189.3 billion by 2032, growing at a CAGR of 16.8%. Key drivers include the increasing prevalence of cancer, the efficacy of ICIs in various cancer types, and expanding indications. The market is segmented by type (PD-1, PD-L1, CTLA-4), application (lung cancer, melanoma, etc.), and geography (North America, Asia-Pacific, etc.).
____
@ end of our website video on these 5 Synergestic MOA's, recent ICI news & it's another $325b potentially effected by LL.
The global radiation oncology market size was exhibited at USD 9.75 billion in 2023 and is projected to hit around USD 31.66 billion by 2033
The global PARP Inhibitors Market was valued at approximately USD 7.9 billion in 2023 and is projected to reach USD 8.4 billion in 2024. By 2033, the market is expected to reach about USD 23.5 billion
The CAR T-Cell therapy market size is calculated at $8.46 bn in 2025 is to hit $88.51 bn by 2034.
The global immune checkpoint inhibitor market is projected to reach $189.3 billion by 2032, growing at a CAGR of 16.8%. Key drivers include the increasing prevalence of cancer, the efficacy of ICIs in various cancer types, and expanding indications. The market is segmented by type (PD-1, PD-L1, CTLA-4), application (lung cancer, melanoma, etc.), and geography (North America, Asia-Pacific, etc.).
____
@ end of our website video on these 5 Synergestic MOA's, recent ICI news & it's another $325b potentially effected by LL.
(7)
(0)
